Compare Vanguard Mega Cap Growth ETF (MGK) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Mega Cap Growth ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Mega Cap Growth ETF trades at $94.42 (market cap $33.70B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is the larger of the two by market cap, and Vanguard Mega Cap Growth ETF is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Mega Cap Growth ETF for 45 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| MGK | XLV | |
|---|---|---|
Market Cap | $33.70B | $43.48B |
Volume | 1,362,010 | 11,121,431 |
Sector | Broad Market / Factor | — |
52-Week High | $95.11 | $175.68 |
52-Week Low | $70.70 | $141.95 |
Typical Hold Time | 45 Days | 100 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MGK, the Vanguard Morningstar Mega Cap Growth ETF, trades at $94.42, down 0.53% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF provides exposure to large-cap U.S. growth stocks like Nvidia and Apple, with a low expense ratio of 0.05% (Vanguard, 2026-07-18). Recent news highlights its strong five-year returns and suitability for long-term growth investors.
The outlook for MGK is positive, driven by its concentrated mega-cap growth holdings and cost efficiency, though risks include tech sector volatility and market concentration. Analyst sentiment is favorable, emphasizing its role in growth portfolios for investors seeking higher returns with manageable risk.
XLV trades at $168.16, down 0.39% on the day, with technical indicators showing a bearish bias as the ETF tests key support levels. The healthcare ETF maintains a competitive 0.08% expense ratio and offers diversified exposure to 60 S&P 500 healthcare stocks. Recent options activity shows increased put volume, suggesting some investor caution despite the sector's defensive characteristics.
The healthcare sector's defensive nature and potential Fed rate hike resilience provide stability, though technical weakness and political volatility around midterm elections present near-term risks. XLV's low-cost structure and broad diversification make it an efficient vehicle for healthcare exposure, but sector-specific headwinds like drug trial failures warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Vanguard Mega Cap Growth ETF
MGK is an ETF that seeks to track the performance of the CRSP US Mega Cap Growth Index. It provides a low-cost, diversified exposure to the largest growth companies in the U.S. stock market. The fund is composed of mega-cap stocks that exhibit key growth factors, including high expected long-term earnings growth, high historical sales and earnings growth, and high return on assets. MGK is typically used by investors seeking long-term capital appreciation from market-leading firms.
Read more on MGK →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
